ASCO: Elinzanetant Cuts Vasomotor Symptoms in Women With Breast Cancer on Endocrine Therapy

TUESDAY, June 3, 2025 (HealthDay News) -- For women with moderate-to-severe vasomotor symptoms associated with endocrine therapy for hormone receptor (HR)-posit